In various human leukemias (such as AML and infant/childhood ALL), expression of mutated FLT3, harboring internal tandem duplications of the juxtamembrane regions (FLT3/ITD), constitutively activates cell proliferation and survival pathways and is associated with poor prognosis. The gene discussed is FLT3; the disease is leukemia.